@Flyingwithwings mtronic counter is just based on rumours. There are no published news regarding any vaccine deal. High risk in my opinion. I dont like to invest in anything that is based purely on rumours.

@oskchoon Don't be a noob and do your research. Only Pfizer vaccine requires -70C storage temperature. Sinopharm vaccine from China only requires 2-8 C storage temperature. Of course Zuellig Pharma which will be collaborating with Kanger has the storage facilities and logistical infrastructure to transport and distribute vaccines that require storage at 2-8 C temperature. They have been doing so for government and private hospitals/ clinics for many many years.

Maybe some from Kstar joined Kanger. Just maybe.

Is this counter linked to vaccine? Any news ?

@kamjiat01 I think my first tp is 0.3

Have to wait patiently for kura-kura to become kangeroo

@Lukesharewalker I really hope thats not the case.

China, 14 Asian nations sign world’s biggest trade deal, India withdrew last year
China and 14 other Asian countries have agreed to form the world’s largest free trade bloc with nearly a third of all economic activity

https://www.nationalheraldindia.com/national/china-14-asian-nations-sign-worlds-biggest-trade-deal-india-withdrew-last-year

Biden's advisers to meet vaccine makers

Joe Biden's scientific advisers will meet with vaccine makers in the coming days as the presidential transition remains stalled because of President Donald Trump's refusal to acknowledge that he lost the election.

A delayed hand-off is especially problematic during a public health crisis, the government's top infectious disease expert said.

https://www.bendigoadvertiser.com.au/story/7013396/bidens-advisers-to-meet-vaccine-makers/?cs=5

Russian vaccine has "claimed" to have efficacy of 92% based on only 20 confirmed cases. Very skeptical about its efficacy.

------------------------

Moscow has claimed its "Sputnik V" vaccine is ever so slightly better than the one produced by the US drugs giant Pfizer.

The Gamalaya Institute says it drew its analysis on the basis of 20 confirmed cases of COVID-19 among trial participants, divided between those given one or both shots of the vaccine and those given a placebo.

The Pfizer interim analysis was based on 94 confirmed cases among its participants. The company said it had decided together with the US Food and Drug Administration (FDA) to drop a first planned analysis based on just 32 cases.

"It's really strange to do the analysis on just 20 cases," Ms Zavidova said.

"How can we draw conclusions about 92% of efficacy, based on that? Maybe they looked at Pfizer's results and just added 2%."

https://news.sky.com/story/covid-19-russias-approach-to-vaccine-rate-race-has-echoes-of-its-spirit-in-the-cold-war-12133042

Incoming Biden chief of staff warns transition delay puts vaccine distribution at risk
“Joe Biden is going to become president of the United States in the midst of an ongoing crisis. That has to be a seamless transition,” Ron Klain said Sunday.

President-elect Joe Biden’s incoming chief of staff, Ron Klain, urged the Trump administration Sunday to reverse course and begin working on a presidential transition so that “nothing drops in this change of power” that would jeopardize the incoming administration’s ability to distribute a coronavirus vaccine.

https://www.nbcnews.com/politics/meet-the-press/incoming-biden-chief-staff-warns-transition-delay-puts-vaccine-distribution-n1247860

Plans for an equitable rollout of Covid-19 vaccinations are being jeopardised by more prosperous countries pre-purchasing the new Pfizer vaccine

There are fears wealthier countries, including New Zealand, are buying up the lion's share of the promising new Covid-19 vaccine – which is not part of the international Covax

https://www.newsroom.co.nz/pro/nz-gets-vaccine-at-expense-of-poor-countries

Hoping to enter below 1.5

COVID-19 vaccine eclipses US elections as economy game-changer

Wall Street rallied on hopeful vaccine news this week as investors eye dawn at the end of a ‘dark winter’.

President Donald Trump may not have moved on from the election yet, but investors sure have.

It started on Monday when Pfizer announced that the COVID-19 vaccine it is developing with Germany’s BioNTech proved 90 percent effective in a late-stage trial.

The prospect of a vaccine on the horizon turbocharged hopes on Wall Street that a pandemic game-changer is within grasp.

https://www.aljazeera.com/economy/2020/11/15/covid-19-vaccine-eclipses-us-elections-as-economy-gamechanger

If it miraculously hit 130 and 135 i will go ALL in but in my opinion highly unlikely.

Russia, China in lead as Philippines seeks deals for Covid-19 vaccines

Duterte said that China and Russia appeared to be ahead in the vaccine race but any country that submitted the best offer could be chosen

Duterte keen to strike Covid-19 vaccine deal with Chinese government

https://newscolony.com/russia-china-in-lead-as-philippines-seeks-deals-for-covid-19-vaccines/

https://www.scmp.com/news/asia/southeast-asia/article/3107198/duterte-wants-deal-chinese-government-provide-covid-19?utm_source=Microsoft&utm_medium=Off-Platform-referrals&utm_campaign=Off-Platform-referrals

Hard to say which direction but likely up. We shall see tomorrow.

I also wished, but i have been observing the weekly trend and it is unlikely to go back to 145.

Unlikely it will go below 15. Lowest i can estimate is 165 as this counter seems to be on higher high higher low trend.

165 is perfect entry price but lets see how the market moves tomorrow.

Hope i still have chance to collect some more.

I wished all investors think like you all but the truth is that many investors are not aware that there is still a need for facemask and gloves even when vaccine is released. Unfortunately, all they see is the vaccine headline which instantly affects the market sentiment. They are unable to reason.

The Malaysian partners in Kanger include Syed Razlan’s wife, Datuk Sharipah Hishmah Sayed Hassan, who is Kanger’s non-executive chairman, and son Syed Hazrain, who is a director. Together with the Raja of Perlis, Tuanku Syed Sirajuddin ibni Tuanku Syed Putra Jamalullail, who is Syed Razlan’s brother, Perlis royalty hold a 9.84% stake in Kanger.

https://www.theedgemarkets.com/article/trade-wise-shoots-enterprise-kanger

Top 30 shareholders of Kanger as of 29/05/2020

http://www.insage.com.my/ir/cmn/trps03/tsh.aspx?Symbol=0170

Covid-19 vaccines: the five frontrunners being eyed up by Argentina's government

https://batimes.com.ar/news/world/covid-19-vaccines-the-frontrunners.phtml

Bargain hunting expected to boost Bursa Malaysia next week

Bursa Malaysia is expected to trade higher next week with investors likely to go on a bargain-hunting mode following last week's losses but progress in the Covid-19 vaccine development will weigh on risk appetite.

https://www.malaymail.com/news/money/2020/11/14/bargain-hunting-expected-to-boost-bursa-malaysia-next-week/1922580

After outcry, finance minister says govt has flexibility to increase Covid-19 funds

“We target half of the RM20 billion to go to initiatives under Kita Prihatin, and the other half of RM10 billion to Covid-19 or the procurement of a vaccine,” he was quoted saying.

Tengku Zafrul reiterated the government’s commitment to obtaining a vaccine for the virus.

“The government is committed to allocating funds to buy vaccines. We’ve discussed the matter with the Science, Technology and Innovation Ministry and the Health Ministry on the RM3 billion allocated for 70 per cent of Malaysians,’’ he said.

https://www.malaymail.com/news/malaysia/2020/11/15/after-outcry-finance-minister-says-govt-has-flexibility-to-increase-covid-1/1922781

In addition, if you are long term investor, you will also reap the benefits from the bamboo business. Kanger is on target to become the world’s largest producer of bamboo products with the commencement of a new high-tech bamboo processing plant and R&D centre in the fourth quarter of 2020 which was developed in collaboration with the local government of Jingzhou in Hunan Province, China. China's economy is also already back to normal.

https://www.thestar.com.my/business/business-news/2020/09/09/kanger-international-on-track-to-be-largest-producer-of-bamboo-products

Also i shouldn't be saying this as i dont like to talk about politics but Kanger has government cable as it is UMNO linked (Johor Umno deputy chief Datuk Nur Jazlan Mohamed is the current chairman). UMNO is currently the king makers in Malaysian politics if you have been following the news. Malaysia will be signing vaccine MOU with China soon by the end of this year. Sinopharm is also owned state owned company in China. So you do the maths of the probability.

Furthermore, Kanger will be collaborating with Zuelling Pharma which has vast experience of storing and distributing vaccines to government as well as private hospitals and clinics all over Malaysia. They have a wide distribution network not just in Malaysia but across South East Asia which is why Kanger chose to collaborate with Zuellig Pharma as they might also be distributing the vaccines across South East Asia as well.

-------------------------------
Kanger International Bhd has roped in Zuellig Pharma Sdn Bhd and K-Star Sport Ltd to collaborate on the distribution of Covid-19 vaccines in Malaysia.

https://www.theedgemarkets.com/article/kanger-ropes-more-collaborators-help-distribute-covid19-vaccines

--------------------------------
"This is a big boost for the pharmaceutical sector. We are moving into the sector through our partnership with one of the top medical groups from China to distribute Covid-19 vaccines here and in Southeast Asia," he said.

https://www.nst.com.my/business/2020/10/632004/kanger-boosted-malaysia-chinas-priority-vaccine-recipient-list

@Ny036 You are absolutely right as it takes time to build up the manpower/ expertise as so far NO manufacturer's in Malaysia have ever conducted fill and finish of bulk vaccines. Also, it takes time to scale up the fill and finish process. It wont happen overnight.

@ Jolly Titijaya will only be distributing medical devices/ medical equipments NOT vaccines. There are different Sinopharm subsidiaries.

Why super-spreaders should be vaccinated early

https://www.smh.com.au/national/nsw/why-super-spreaders-should-be-vaccinated-early-20201112-p56dyc.html

@Ny036 We do not know about Pharma or Dpharma as it was not even confirmed they will be conducting fill an finish of covid vaccines and even if they were, we do not know which vaccine will be imported in bulk for fill and finish. The only counter confirmed to be link to Sinopharm is Kanger..

Vaccines have never been distributed equally. A coronavirus vaccine would be no different, history suggests.

Wealthy countries have bought up a major share of the available supply, my colleagues Emily Rauhala and Joanna Slater report.

“The United States, the United Kingdom, Japan and Canada have struck deals large enough to vaccinate their entire populations. By contrast, a pooled global effort to distribute vaccines equitably to more than 150 countries — including dozens of low-income nations — has secured only 700 million doses,” Slater writes.

https://www.washingtonpost.com/world/2020/11/12/vaccine-distribution-history-coronavirus-h1n1-h5n1/

Conducted in Morocco among others, SINOPHARM'S Covid vaccine trials show «better-than-expected» data

We are impatiently awaiting the end of this process, which could probably happen by NEXT WEEK, to then receive the results from the Chinese laboratory», he concluded.

https://en.yabiladi.com/articles/details/101544/conducted-morocco-among-others-sinopharm-s.html

Conducted in Morocco among others, SINOPHARM'S Covid vaccine trials show «better-than-expected» data

We are impatiently awaiting the end of this process, which could probably happen by NEXT WEEK, to then receive the results from the Chinese laboratory», he concluded.

https://en.yabiladi.com/articles/details/101544/conducted-morocco-among-others-sinopharm-s.html

Conducted in Morocco among others, SINOPHARM'S Covid vaccine trials show «better-than-expected» data

We are impatiently awaiting the end of this process, which could probably happen by NEXT WEEK, to then receive the results from the Chinese laboratory», he concluded.

https://en.yabiladi.com/articles/details/101544/conducted-morocco-among-others-sinopharm-s.html

Solutions's Cansino vaccine, phase III trials are expected to conclude in 2022.

Chinese vaccine company CanSino Biologics, one of the frontrunners for a COVID-19 vaccine, is slated to conclude phase III trials of its vaccine candidate Ad5-nCoV in January 2022.

https://fortune.com/2020/10/27/china-covid-vaccine-cansino-timeline-january-2022/

------------------------------

Phase III Trial of A COVID-19 Vaccine of Adenovirus Vector in Adults 18 Years Old and Above
Estimated Study Completion Date : January 30, 2022

https://clinicaltrials.gov/ct2/show/NCT04526990

Goverment hospitals only have storage facility to store at 2-8 C. I know because i have worked in goverment hospital before.

@MadCow75 Goverment hospitals do not have storage facility to store at -70C. No such vaccine that requires -70C have ever been produced worldwide.

As for Solutions's Cansino vaccine, phase III trials are expected to conclude in 2022.

Chinese vaccine company CanSino Biologics, one of the frontrunners for a COVID-19 vaccine, is slated to conclude phase III trials of its vaccine candidate Ad5-nCoV in January 2022.

https://fortune.com/2020/10/27/china-covid-vaccine-cansino-timeline-january-2022/

------------------------------

Phase III Trial of A COVID-19 Vaccine of Adenovirus Vector in Adults 18 Years Old and Above
Estimated Study Completion Date : January 30, 2022

https://clinicaltrials.gov/ct2/show/NCT04526990

Click on this link and type in Generex in the search box. Generex vaccine is still in pre-clinical stage.

https://www.raps.org/news-and-articles/news-articles/2020/3/covid-19-vaccine-tracker

Only rich countries are capable to build the logistical infrastructure necessary to transport Pfizer vaccine at -70C/

@MadCow75 Yes, most developed countries already pre-booked Pfizer Vaccine. See this link
https://timesofindia.indiatimes.com/world/rest-of-world/as-rich-nations-hoard-vaccines-covid-fight-could-stretch-to-2024/articleshow/79228706.cms

@pauthesotong Please click on this link and type in Generex in the search box. It is still in pre-clinical stage.
https://www.raps.org/news-and-articles/news-articles/2020/3/covid-19-vaccine-tracker

@paulthesotong Why would i want to go to Bintai? Generex vaccine is still in preclinical stage lol

Unfortunately the market doesn't think that way due to bad sentiment. It is pure bad luck. Any vaccine news seems to affect both glove and facemask counters at the same time as we have seen with the release of Pfizer vaccine news. Even Moderna vaccine will be releasing their results soon. With more and more vaccine news coming out, i wonder how this counter will perform.

@pauthesotong Thats is what Pfizer is researching into but it is going to be a long time more, most probably end of 2021

As rich nations hoard vaccines, Covid fight could stretch to 2024

https://timesofindia.indiatimes.com/world/rest-of-world/as-rich-nations-hoard-vaccines-covid-fight-could-stretch-to-2024/articleshow/79228706.cms

--------------------

We’ll need more than one vaccine to beat the pandemic
All COVID vaccine candidates work in different ways; none will be perfect for all.

https://arstechnica.com/science/2020/11/well-need-more-than-one-vaccine-to-beat-the-pandemic/